Recombinant Streptokinase is a potent "clot-busting" protein produced through DNA technology. It works by binding with plasminogen to form an active complex that converts free plasminogen into plasmin. Plasmin is the enzyme responsible for digesting fibrin, the main structural component of blood clots. By rapidly dissolving these obstructions (thrombolysis), Streptokinase restores blood flow to oxygen-deprived tissues, significantly reducing heart muscle damage during a heart attack or brain tissue damage during specific types of strokes.
In Nigeria, Recombinant Streptokinase (typically 1.5 million IU) is a life-saving clinical choice for emergency cardiovascular care. It is available through specialist hospital pharmacies like Sanlive Pharmacy to ensure medical facilities receive authentic, high-purity vials manufactured under strict biotechnology standards and stored in refrigerated, climate-controlled environments ($2^\circ\text{C}$ to $8^\circ\text{C}$) to maintain the enzymatic activity of the recombinant protein.
Important: This is a high-alert, hospital-only emergency medication. The "Golden Hour" Rule: To be effective, Streptokinase must be administered as soon as possible after the onset of symptoms (ideally within 6 to 12 hours). Bleeding Risk: Because it systemically dissolves clots, there is a significant risk of internal bleeding. Strictly Contraindicated: Do not use if the patient has had surgery, a stroke, or severe head trauma within the last 3 months, or has active internal bleeding, severe uncontrolled hypertension, or a known allergy to Streptokinase.
Recombinant Streptokinase for Injection is primarily used to:
Treat Acute Myocardial Infarction (Heart Attack) by dissolving clots in the coronary arteries
Manage Acute Massive Pulmonary Embolism (large clots in the lungs)
Treat Deep Vein Thrombosis (DVT) when there is a high risk of permanent vein damage
Clear Acute Arterial Thromboembolism (clots in the limb arteries)
Restore patency to occluded intravenous or arterial cannulae (at much lower doses)
Significantly improve survival rates and long-term cardiac function following a major blockage
This product is suitable for:
Adult patients presenting with clinical signs of a heart attack and specific ECG changes (ST-segment elevation)
Patients with life-threatening pulmonary emboli who are hemodynamically unstable
Individuals requiring rapid chemical dissolution of a dangerous, newly formed blood clot
Not recommended for: Children (unless in rare, specialized pediatric cardiac cases). It is strictly contraindicated for patients with a history of "streptococcal" infections in the last 6 months, as existing antibodies may neutralize the drug or cause a severe allergic reaction. Consult the attending cardiologist regarding use in elderly patients over 75, as the risk of intracranial hemorrhage (brain bleeding) is higher.
Administered strictly by intravenous (IV) or intracoronary infusion by a trained physician in a monitored setting (ICU or ER)
Reconstitution: The vial must be gently dissolved with Physiological Saline or 5% Dextrose; do not shake the vial, as this can foam the protein and destroy its activity
Standard Adult Dose: For a heart attack, 1.5 million IU is typically infused over 60 minutes
Monitoring: Continuous ECG monitoring and frequent blood pressure checks are mandatory during the infusion
Patients are usually started on anticoagulants (like Heparin) or antiplatelets (like Aspirin) after the Streptokinase infusion is complete to prevent the clot from reforming
The drug is usually a one-time treatment; repeat doses are avoided due to the development of antibodies
Streptokinase is a powerful enzyme, and side effects are common:
Low blood pressure (hypotension) during the infusion (very common)
Bleeding at the injection site, gums, or nose
Irregular heartbeats (reperfusion arrhythmias) as blood flow returns to the heart
Fever, chills, or a mild skin rash
Rare but serious: Spontaneous internal bleeding (stomach or brain)
Rare: Severe allergic reaction (anaphylaxis)
Seek immediate emergency intervention if the patient shows signs of a stroke (sudden confusion or weakness), severe abdominal pain, or heavy, uncontrollable bleeding from any site.
Reputable biotechnology firms – These manufacturers use recombinant DNA technology to ensure the Streptokinase is free from the bacterial impurities often found in older, non-recombinant versions.
100% authentic, cold-chain managed medication—guaranteed 100% potency
Guaranteed sterile, factory-sealed vials stored in specialized medical refrigerators
Professional support for hospital procurement departments on emergency stock management
Fast and secure delivery to hospitals, clinics, and emergency centers across Nigeria
Can I get this injection a second time if I have another heart attack?
Usually, no. After the first dose, your body develops "anti-streptokinase" antibodies that stay in your blood for months or years. If you take it again, your body might attack the drug, making it useless or causing a severe allergy. A different type of "clot-buster" (like Alteplase) would be used instead.
How do I know if the drug worked?
Doctors will look for a sudden decrease in chest pain and specific changes on your heart monitor (ECG). They may also perform a follow-up procedure to look at the blood flow in your heart.
Is it safe for pregnant women?
It is generally avoided during pregnancy, especially in the first 18 weeks and near the time of delivery, due to the high risk of severe maternal bleeding. It is only used if the mother's life is in immediate danger.
Where can I purchase Recombinant Streptokinase in Nigeria?
Hospitals and emergency units can source verified Recombinant Streptokinase through Sanlive Pharmacy & Stores for guaranteed product integrity and expert clinical support.
No reviews yet.
Login to write a review.
Related Products
.jpg)
